Great saphenous vein
The Great Saphenous Vein (GSV) is the largest vein in the human body, and is also known as the long saphenous vein. It is a superficial vein, meaning it is close to the surface of the body, and it runs along the length of the lower limb, returning blood from the foot, leg and thigh to the deep femoral vein at the femoral triangle.
Anatomy[edit]
The GSV originates from where the dorsal vein of the first digit (big toe) merges with the dorsal venous arch of the foot. After this junction, it runs up in front of the medial malleolus (part of the tibia bone) and along the medial side of the leg. At the knee, it runs over the posterior border of the medial epicondyle of the femur bone. The vein then courses up the medial side of the thigh to ultimately join with the femoral vein.
Clinical Significance[edit]
The Great Saphenous Vein is often used in coronary artery bypass surgery. The vein is harvested from the leg and used to bypass blocked coronary arteries. This is possible because veins can handle the lower pressure environment found in veins as compared to arteries.
In addition, the GSV can become varicose, a condition known as varicose veins. This is when the vein becomes enlarged and overfilled with blood, causing it to appear raised and swollen. Varicose veins can cause aching pain and discomfort, and in some cases, can lead to more serious problems.
See Also[edit]
References[edit]
-
Anatomical illustration of the great saphenous vein
-
Great saphenous vein in a clinical slide
-
Great saphenous vein in a different clinical slide
-
Diagram showing leg veins including the great saphenous vein
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
